Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$1.12 - $2.18 $2,494 - $4,854
2,227 Added 2.26%
100,801 $131,000
Q1 2022

May 02, 2022

BUY
$1.63 - $3.63 $31,465 - $70,073
19,304 Added 24.35%
98,574 $265,000
Q4 2021

Jan 28, 2022

BUY
$2.25 - $4.11 $63,636 - $116,243
28,283 Added 55.47%
79,270 $179,000
Q3 2021

Nov 16, 2021

BUY
$2.71 - $5.9 $44,088 - $95,987
16,269 Added 46.86%
50,987 $206,000
Q2 2021

Aug 10, 2021

BUY
$4.83 - $9.67 $30,144 - $60,350
6,241 Added 21.92%
34,718 $172,000
Q1 2021

May 13, 2021

BUY
$6.01 - $8.9 $171,146 - $253,445
28,477 New
28,477 $190,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $78.2M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.